P
US5637682AExpiredUtilityPatentIndex 90

High-affinity oligonucleotide ligands to the tachykinin substance P

Assignee: NEXSTAR PHARMACEUTICALS INCPriority: Jun 11, 1990Filed: May 16, 1995Granted: Jun 10, 1997
Est. expiryJun 11, 2010(expired)· nominal 20-yr term from priority
Inventors:NIEUWLANDT DAN TGOLD LARRYWECKER MATTHEW
C12N 15/115B82Y 5/00C07H 19/06C07H 19/10C07H 21/00C07K 14/001C07K 14/70571C12N 15/1048C12Q 1/6811C40B 40/00G01N 33/531G01N 33/532G01N 33/535G01N 33/56988G01N 33/68G01N 33/76G01N 2333/16G01N 2333/163G01N 2333/503G01N 2333/575G01N 2333/62G01N 2333/8125G01N 2333/96433G01N 2333/96455G01N 2333/966G01N 2333/9726G01N 2333/974G01N 2333/976A61K 47/547A61K 47/549
90
PatentIndex Score
27
Cited by
38
References
7
Claims

Abstract

Methods are described for the identification and preparation of nucleic acid ligands to Substance P (SP). Included in the invention are specific RNA ligands to SP identified by the SELEX method.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A nucleic acid ligand to Substance P (SP) identified according to a process comprising the steps of: a) contacting a candidate mixture of nucleic acids with SP, wherein nucleic acids having an increased affinity to the SP relative to the candidate mixture may be partitioned from the remainder of the candidate mixture;   b) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; and   c) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched in nucleic acids having increased affinity to SP, whereby a nucleic acid ligand of SP may be identified.   
     
     
       2. The nucleic acid ligand of claim 1 which is an RNA ligand, wherein the nucleotide sequence of said ligand is selected from the group consisting of the sequences set forth in FIGS. 2 and 3. 
     
     
       3. The RNA ligand of claim 2 wherein said ligand is selected from the group consisting of SEQ ID NOS:5, 18-21, 26-47 and 58. 
     
     
       4. The RNA ligand of claim 2 wherein said ligand is comprised of 2'-amino (2'-NH 2 ) modified nucleotides. 
     
     
       5. A purified and isolated non-naturally occurring nucleic acid ligand to SP. 
     
     
       6. The nucleic acid ligand of claim 5 which is an RNA ligand. 
     
     
       7. The nucleic acid ligand of claim 1 wherein said ligand comprises 2'-amino (2'-NH 2 ) modified nucleotides.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.